Picard Medical Holds Annual Meeting; Approves Reverse Split & Class B Stock

What Happened
Picard Medical, Inc. announced the results of its Annual Meeting of Stockholders held July 17, 2026 (record date: June 26, 2026; 102,695,935 shares entitled to vote). Shareholders approved all proposals in the company’s proxy, including a charter amendment authorizing a reverse stock split at a ratio between 1-for-15 and 1-for-50 (exact ratio and timing to be set by the Board), and an amendment to designate Class B common stock with 20 votes per share. All director nominees were elected, the company’s named executive officer compensation was approved in an advisory vote (say-on-pay) on a one-year frequency, and MaloneBailey LLP was ratified as the independent registered public accounting firm for 2026.

Key Details

• Reverse split amendment approved: authorization to effect a reverse stock split between 1-for-15 and 1-for-50; vote: For 58,138,876 / Against 785,970 / Abstain 45,196. Board will determine exact ratio and timing, if any.
• Class B designation approved: creates Class B common stock with 20 votes per share; vote: For 51,739,973 / Against 4,938,305 / Abstain 9,327 (2,282,437 broker non-votes).
• Director elections: Richard Fang, Sam Van, Joe Xiao and George Ye were elected to terms expiring 2027 (vote totals ranged ~54M–56.3M in favor, with broker non-votes of 2,282,437).
• Say-on-pay and frequency: advisory approval of named executive officer compensation (For 56,104,172 / Against 490,596 / Abstain 92,837) and approval to hold future advisory votes on pay annually (1-year received majority).
• Auditor ratified: MaloneBailey LLP ratified as independent registered public accounting firm for 2026 (For 58,514,997 / Against 137,804 / Abstain 317,241).

Why It Matters
These shareholder approvals give the Board authority to reduce the number of outstanding shares via a potentially large reverse split (1-for-15 to 1-for-50) and to create a dual-class structure with high-vote Class B shares (20 votes each). Both actions can materially affect share count, voting power and per-share market metrics once implemented; however, the Board must still decide whether and how to proceed. The re-election of directors, ratification of the auditor, and annual say-on-pay give investors continuity and indicate shareholder support for current governance and executive compensation policies. Investors should monitor future filings for the Board’s decision on any reverse split and any issuance or allocation plan for Class B shares.